Pennant Group, Inc. (PNTG): M&A transaction — Pennant completes $48.5M Oregon acquisition of Signature Healthcare at Home

Pennant Group, Inc.

Oregon portion closed Jan 1, 2025; total two-stage acquisition now complete.
Purchase price for Oregon assets: $48.48M in cash on hand.
Oregon assets include seven locations, expanding Pennant's Pacific Northwest footprint.
Combined with prior $32M Idaho/Washington close on Aug 1, 2024, total deal ~$80.5M.
No material relationship between Pennant and sellers; cultural alignment cited by management.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Pennant Group, Inc. completed an acquisition involving Signature Healthcare at Home (Signature) for $48,480,000 (closed 2025-01-01).

Action: acquisition
Counterparty: Signature Healthcare at Home (Signature)
Consideration: $48,480,000
Closing: 2025-01-01

Exact text from the filing

This portion of the acquisition closed on January 1, 2025. The purchase price was $48,480,000.

View on SEC.gov

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Pennant Group, Inc. completed an acquisition involving Avamere Home Health Care, LLC; Prime Home Health, LLC; A-One Home Health Services, LLC; and Signature Hospice Nampa, LLC for $32,000,000 (closed 2024-08-01).

Action: acquisition
Counterparty: Avamere Home Health Care, LLC; Prime Home Health, LLC; A-One Home Health Services, LLC; and Signature Hospice Nampa, LLC
Consideration: $32,000,000
Closing: 2024-08-01

Exact text from the filing

This portion of the acquisition closed on August 1, 2024. The purchase price was $32,000,000.

View on SEC.gov

Browse all m&a transactions →

Pennant Group, Inc. filing history →

Source: SEC EDGAR

accession 0001766400-25-000003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.